comparemela.com

Latest Breaking News On - Charles bankhead - Page 1 : comparemela.com

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

Co-mutations, viral link, potential common susceptibility emerge from two studies

Stanford universityUnited statesUnited kingdomMedstar georgetown university hospitalDistrict of columbiaEmily mitchellCharles bankheadMetin ozdemirliGeorges vassiliouUniversity of cambridgeAsh alizadehNew england journalMedpage todayEngland journalEnglj med

Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer

No difference in PFS, median OS favored control group

France generalSouth koreaCharles bankheadColler nanoliposomalLinstitut mutualiste montsourisDavid malkaArndt vogelGastroenterol hepatolHannover medical schoolLancet gastroenterologyMedpage today

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Half of patients responded, but editorialists call for new directions in therapy development

United statesDana farber cancer instituteJia luoCharles bankheadLiza villaruzHillman cancer centerShanghai jiao tong universityLancet respiratoryCancer centerMedpage todayRespir med

Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy

All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years

United statesJillian guntherCharles bankheadPeter meidahl petersenDorte schouUniversity of texas md anderson cancer centerCopenhagen university hospitalCancer centerMedpage today

Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma

A third as many clinical events versus adjuvant therapy, 6 weeks of treatment for many patients

Noord hollandUnited statesCharles bankheadMichael loweJulie gralowNetherlands cancer instituteAmerican society of clinical oncologyEmory university in atlantaAmerican societyClinical oncologyEmory universityMedpage today

vimarsana © 2020. All Rights Reserved.